All Pharma News
BioLineRx Presents Apheresis Center Efficiency Data on APHEXDA®

BioLineRx Presents Apheresis Center Efficiency Data on APHEXDA®
PR NEWSWIRE
17 Apr 2024
Share Share
BioLineRx Accesses Second Tranche of $20M Financing

BioLineRx Accesses Second Tranche of $20M Financing
PR NEWSWIRE
10 Apr 2024
Share Share
BioLineRx Announces $6 Million Registered Direct Offering

BioLineRx Announces $6 Million Registered Direct Offering
PR NEWSWIRE
01 Apr 2024
Share Share
BioLineRx Reports 2023 Financial Results

BioLineRx Reports 2023 Financial Results
PR NEWSWIRE
26 Mar 2024
Share Share
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results

IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results
PR NEWSWIRE
20 Mar 2024
Share Share
BioLineRx to Report 2023 Annual Financial Results on March 26, 2024

BioLineRx to Report 2023 Annual Financial Results on March 26, 2024
PR NEWSWIRE
20 Mar 2024
Share Share
BioLineRx Strengthens Intellectual Property Estate

BioLineRx Strengthens Intellectual Property Estate
PR NEWSWIRE
04 Mar 2024
Share Share
BioLineRx Announces First Patient Dosed in Ph 2 Trial Evaluating Motixafortide

BioLineRx Announces First Patient Dosed in Ph 2 Trial Evaluating Motixafortide
PR NEWSWIRE
28 Feb 2024
Share Share
BioLineRx Announces Acceptance of Two Poster Presentations on APHEXDA

BioLineRx Announces Acceptance of Two Poster Presentations on APHEXDA
PR NEWSWIRE
16 Feb 2024
Share Share
BioLineRx Announces First Patient Dosed in Ph 1 Trial Evaluating Motixafortide

BioLineRx Announces First Patient Dosed in Ph 1 Trial Evaluating Motixafortide
PR NEWSWIRE
21 Dec 2023
Share Share